Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for AZTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 328.21M
March 31, 2026 382.93M
December 31, 2025 412.05M
September 30, 2025 343.28M
June 30, 2025 321.17M
March 31, 2025 330.44M
December 31, 2024 465.52M
September 30, 2024 433.26M
June 30, 2024 598.61M
March 31, 2024 824.80M
December 31, 2023 988.93M
September 30, 2023 1.022B
June 30, 2023 1.126B
March 31, 2023 1.185B
December 31, 2022 1.138B
September 30, 2022 1.953B
June 30, 2022 2.195B
March 31, 2022 2.756B
December 31, 2021 218.79M
September 30, 2021 234.65M
June 30, 2021 273.53M
March 31, 2021 323.78M
December 31, 2020 312.14M
September 30, 2020 254.27M
June 30, 2020 256.77M
Date Value
March 31, 2020 245.96M
December 31, 2019 350.08M
September 30, 2019 339.30M
June 30, 2019 156.89M
March 31, 2019 137.26M
December 31, 2018 135.82M
September 30, 2018 243.99M
June 30, 2018 221.47M
March 31, 2018 234.67M
December 31, 2017 218.00M
September 30, 2017 101.65M
June 30, 2017 117.09M
March 31, 2017 105.43M
December 31, 2016 83.81M
September 30, 2016 85.12M
June 30, 2016 66.13M
March 31, 2016 62.23M
December 31, 2015 55.61M
September 30, 2015 150.74M
June 30, 2015 141.22M
March 31, 2015 142.50M
December 31, 2014 136.41M
September 30, 2014 162.24M
June 30, 2014 172.62M
March 31, 2014 135.56M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 1.758B
Bio-Rad Laboratories, Inc. 1.620B
Bruker Corp. 222.50M
Danaher Corp. 4.348B
Harvard Bioscience, Inc. 6.503M